Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
about
Genetic susceptibility to lung cancer and co-morbiditiesDiesel exhaust: current knowledge of adverse effects and underlying cellular mechanismsGenomic impact of cigarette smoke, with application to three smoking-related diseasesIntegrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPDA randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept studyState-of-the-art MS technology applications in lung disease.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair.Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.General mechanisms of nicotine-induced fibrogenesis.IL-17 induces EMT via Stat3 in lung adenocarcinomaThe clinical impact of non-obstructive chronic bronchitis in current and former smokers.Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.miR-638 regulates gene expression networks associated with emphysematous lung destruction.How the genetics of lung cancer may overlap with COPD.Genomics and the respiratory effects of air pollution exposure.Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia.Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer: Epithelial Mesenchymal Transition (EMT), the Missing Link?The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer.Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease.Mammalian target of rapamycin complex 2 regulates inflammatory response to stress.Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges.β-catenin, Twist and Snail: Transcriptional regulation of EMT in smokers and COPD, and relation to airflow obstruction.Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activationA modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue.Transforming growth factor (TGF) β1 and Smad signalling pathways: A likely key to EMT-associated COPD pathogenesis.East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin Disease.Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer
P2860
Q24606717-A784CC11-CC2A-4695-9110-86742DAAB7D5Q26750759-4BB8DC31-F8C1-4479-B472-A09A3736E9A6Q27027763-6167CF16-92F0-4470-AFF3-0C10DF2E36BEQ33704760-72F02F22-DFFB-4E62-A936-0F1669D75E26Q33705875-65AB5C6F-C955-4411-BF13-906FD9B0F49BQ34089332-DD07762F-A2A5-4971-AD85-BCD70800B3E4Q34350843-49DB6499-5591-4103-A292-562B6A111788Q34558199-B85CDBD9-C3AC-4C2A-828B-2C9968316FC8Q34656726-ACF08A24-25C7-4236-AAA6-C79845030F97Q35550738-B33F9FCE-4A81-41A3-8182-42E5FD2ED1D1Q35764015-F8DDA760-5144-4682-81E5-DED93EF42F6BQ35935002-4D348908-FA2F-42E9-9F3C-C84EDE8DC542Q36112558-15E283ED-0A47-467A-88B3-8099B894751AQ36148775-80DEEE5F-10F4-42E8-9C11-A9B9EEC53FB2Q36320998-D54DEAD1-18CD-4F32-9E60-F3108F0D5DEEQ36430810-AB3EA74F-768B-45E4-A7CE-F7BEA8C11A57Q36878756-69D3694D-C943-402E-9CCC-C43CF16C8551Q37619677-E49139CA-B596-423D-9B3C-FE878BC19CD0Q37644907-A16A41DF-9A35-4EF1-AFD2-118F6A367A04Q37676834-F365186F-D56D-4350-9E84-B39914149BDDQ37900349-0023A481-6F33-45F5-9D63-E677DAB790C7Q37992116-C779179B-6D92-4EB4-B3CE-57D30D82455DQ38020235-A3AAB0FD-9D55-40DF-9AC6-BBE1F0EA1C29Q38153817-71726233-D1A5-449A-A2A7-584CBF3951A4Q38155607-23D9097C-809E-4D75-A372-63C2A86FF55EQ38255396-E4D21F1A-CA36-4751-A324-45B208F1BB58Q38335339-C33DF830-728E-4C22-B971-2E24FB7ECCE7Q39395614-C23B38AE-FB23-416E-95B1-A2B0D3626926Q41201843-5E6876C6-652D-4228-AE6A-F56B0BED0FDFQ41432497-65DE3491-50CE-4CC7-AF72-9CBDA3D24A24Q41538152-274B2A38-A961-45E5-A8F0-863D1742247EQ41617768-03F8DF8B-2BC9-4CB4-9159-003024B77DEFQ42225227-71D310FE-243A-48DE-9137-0E0256EFEE6EQ42498785-CABC0F21-87CD-455F-884C-1A979FE32635Q51733163-AF25EC17-9C2A-48A8-A8C2-03E95BDA484DQ58572012-09AE90E2-9585-4FC7-BF9B-75AF3F4787D6
P2860
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@en
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@nl
type
label
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@en
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@nl
prefLabel
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@en
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.
@nl
P2093
P2860
P1476
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer
@en
P2093
Belinda E Clarke
Edwina E Duhig
Ian A Yang
Krishna B Sriram
Kwun M Fong
Morgan R Davidson
Rayleen V Bowman
Santiyagu M Savarimuthu Francis
Vandana Relan
P2860
P304
P356
10.1517/14728222.2011.555400
P407
P577
2011-02-02T00:00:00Z